|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.99 CNY | +1.92% |
|
+15.72% | -10.16% |
Dizal (Jiangsu) Pharmaceutical Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported net loss was CNY 344.9 million compared to CNY 298.58 million a year ago. Basic loss per share from continuing operations was CNY 0.85 compared to CNY 0.83 a year ago.
Diluted loss per share from continuing operations was CNY 0.85 compared to CNY 0.83 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -10.16% | 2.42B | |
| -2.26% | 104B | |
| +1.41% | 97.42B | |
| +0.79% | 22.2B | |
| -17.84% | 21.23B | |
| -11.11% | 18.33B | |
| -42.83% | 16.35B | |
| -17.63% | 15.06B | |
| +4.55% | 13.98B | |
| +32.11% | 11.66B |
DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. 
